Indian Pharma Stocks Outlook: Why Satish Ramanathan Turns Bullish On Pharma

Pharma stocks are back in focus as investors look for defensive opportunities amid global uncertainty. Satish Ramanathan, CIO-Equity, JM Financial AMC, explains why Indian pharmaceutical companies continue to remain well-positioned despite concerns around U.S. tariffs and trade restrictions. He discusses the strength of India's generic drug industry, opportunities arising from key drugs going off patent, and the outlook for domestic pharma, exporters and the CDMO segment.